CI vs HUM — Key Metrics
| Metric | CI (CIGNA GROUP) | HUM (HUMANA INC) |
|---|---|---|
| Price | 285.37 | 385.78 |
| Market Cap | 75.2 Billion | 46.33 Billion |
| P/E (TTM) | 12.53 | 37.17 |
| P/B (Quarterly) | 1.831 | 2.767 |
| P/S (TTM) | 0.26 | 0.3 |
| Net Profit Margin (TTM) | 2.1 | 0.8 |
| Gross Margin (TTM) | 9.1 | 13.0 |
| ROE (TTM) | 14.1 | 6.7 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Greatly Outperform
Outperform
Recommendation Summary
Stock CI is projected to greatly outperform the market, stock HUM is projected to outperform the market. Upfront Recommendation: CI.
Financial Metrics
| CI | Metrics | HUM |
|---|---|---|
| $285.37 | Price | $385.78 |
| — | Market Capitalization | — |
| 12.53 | Price to Earnings Ratio | 37.17 |
| 0.26 | Price to Sales | 0.3 |
| 9.1 | Price to FCF Ratio | 14.65 |
| 2.89 | Price to Gross Profit | 2.31 |
| 1.59 | Price to Current Assets | 1.17 |
CI vs HUM at a glance
Cigna Group (CI) and Humana INC (HUM) are both Healthcare Plans companies in the Healthcare sector. CI is the larger, at $75.2 billion in market value against $46.3 billion for HUM, about 1.6 times the size.
On trailing-twelve-month figures, CI trades at 12.5 times trailing earnings and HUM at 37.2; net profit margins are 2.1% and 0.8%.
The Upfront Investment model currently rates CI Greatly Outperform and HUM Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.